Vicor Equity Method Investments increased by 1.9% to $2.51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.9%, from $2.66M to $2.51M. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows relatively stable performance with a -0.4% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.56M | $2.60M | $2.64M | $2.54M | $2.55M | $2.55M | $2.62M | $2.63M | $2.59M | $2.61M | $2.53M | $2.62M | $2.60M | $2.64M | $2.64M | $2.66M | $2.58M | $2.41M | $2.46M | $2.51M |
| QoQ Change | — | +1.4% | +1.6% | -3.9% | +0.6% | +0.0% | +2.7% | +0.3% | -1.5% | +0.8% | -3.1% | +3.6% | -0.8% | +1.5% | +0.0% | +0.9% | -3.0% | -6.9% | +2.3% | +1.9% |
| YoY Change | — | — | — | — | -0.4% | -1.8% | -0.6% | +3.7% | +1.5% | +2.3% | -3.5% | -0.3% | +0.3% | +1.1% | +4.4% | +1.6% | -0.6% | -8.9% | -6.8% | -5.9% |